alendronate has been researched along with Prediabetic State in 1 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Prediabetic State: The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| " We aimed to determine the effect of alendronate on plasma glucose, insulin indices of postmenopausal women with prediabetes and osteopenia." | 9.30 | Alendronate improves fasting plasma glucose and insulin sensitivity, and decreases insulin resistance in prediabetic osteopenic postmenopausal women: A randomized triple-blind clinical trial. ( Amini, M; Aminorroaya Yamini, S; Aminorroaya, A; Feizi, A; Hadi Alijanvand, M; Kachuei, A; Karimi Fard, M; Karimifar, M; Salamat, MR, 2019) |
| " We aimed to determine the effect of alendronate on plasma glucose, insulin indices of postmenopausal women with prediabetes and osteopenia." | 5.30 | Alendronate improves fasting plasma glucose and insulin sensitivity, and decreases insulin resistance in prediabetic osteopenic postmenopausal women: A randomized triple-blind clinical trial. ( Amini, M; Aminorroaya Yamini, S; Aminorroaya, A; Feizi, A; Hadi Alijanvand, M; Kachuei, A; Karimi Fard, M; Karimifar, M; Salamat, MR, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karimi Fard, M | 1 |
| Aminorroaya, A | 1 |
| Kachuei, A | 1 |
| Salamat, MR | 1 |
| Hadi Alijanvand, M | 1 |
| Aminorroaya Yamini, S | 1 |
| Karimifar, M | 1 |
| Feizi, A | 1 |
| Amini, M | 1 |
1 trial available for alendronate and Prediabetic State
| Article | Year |
|---|---|
Alendronate improves fasting plasma glucose and insulin sensitivity, and decreases insulin resistance in prediabetic osteopenic postmenopausal women: A randomized triple-blind clinical trial.
Topics: Alendronate; Biomarkers; Blood Glucose; Bone Density Conservation Agents; Bone Diseases, Metabolic; | 2019 |